Request availability and a quotation for your required quantity and destination.
| Product | Imiquimod 5% - Imiquad Cream |
|---|---|
| Categories | Skin Care |
| Pack Size | 30 Sachet, 60 Sachet, 90 Sachet |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Product category: Skin Care
Active ingredient: Imiquimod 5%
Dosage form: Topical cream
Prescription: Required
Imiquad is an imiquimod topical immune-response modifier. Reference labeling describes treatment of specific actinic keratoses, certain biopsy-confirmed superficial basal cell carcinomas and external genital/perianal warts. Verify the exact supplied brand leaflet and local approved uses.
An accurate diagnosis is essential. Imiquimod is not a general treatment for acne, pigmentation, arbitrary skin growths or every skin cancer. Regimens differ greatly between conditions and should be prescribed individually.
Redness, erosion, itching, swelling, flaking and flu-like symptoms may occur. Protect the skin from excess ultraviolet exposure and avoid internal or mucosal application. Serious or extensive reactions warrant prompt medical care.
Selected actinic keratoses, certain superficial basal cell carcinomas and external genital/perianal warts, when diagnosed and prescribed.
No. It modifies the local immune response.
No. Acne is not an approved indication.
No. Only selected biopsy-confirmed superficial basal cell carcinomas qualify; medical follow-up is essential.
It may clear visible external warts but does not eliminate HPV infection.
No. The reference cream is for specified external skin areas only.
Yes. Redness, burning, swelling and erosions can occur; severe symptoms need review.
No. Frequency and duration vary substantially by diagnosis.
Yes. Minimize UV exposure as directed by the prescriber.
Pregnancy or breastfeeding requires individualized professional assessment.
Cureiva provides educational product information and evaluates enquiries subject to prescriptions, availability and destination-country rules. Content is source-informed, not independently physician-signed.